Optimal thromboprophylaxis remains a challenge
BJU Int
.
2016 Sep;118(3):342.
doi: 10.1111/bju.13548.
Author
Daniel Eberli
1
Affiliation
1
University and University Hospital of Zurich, Zurich, Switzerland.
PMID:
27524715
DOI:
10.1111/bju.13548
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants*
Humans
Venous Thromboembolism*
Substances
Anticoagulants